--- title: "Pre-market hot trades in US stocks: Snowflake up 3.37% in pre-market as Citigroup raises target price to $395" type: "News" locale: "en" url: "https://longbridge.com/en/news/297178394.md" description: "Snowflake pre-market up 3.37%; Volitionrx pre-market up 96.55%; Mercer International pre-market up 51.09%; Youxin Tech pre-market up 44.05%" datetime: "2026-08-27T11:37:29.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/297178394.md) - [en](https://longbridge.com/en/news/297178394.md) - [zh-HK](https://longbridge.com/zh-HK/news/297178394.md) generator: "portal-rs" --- # Pre-market hot trades in US stocks: Snowflake up 3.37% in pre-market as Citigroup raises target price to $395 **Pre-market Hot Trades in US Stocks** Snowflake is up 3.37% in pre-market trading. Based on recent key news: 1. On August 27, analysts expect Snowflake to exceed second-quarter earnings expectations, with product revenue growing 30% year-over-year and an operating margin of 12.5%. This expectation has boosted market confidence and driven the stock price up. 2. On August 27, Citigroup raised Snowflake's target price from $320 to $395 and maintained a "Buy" rating. The target price increase further enhanced investor optimism, promoting the stock price rise. 3. On August 26, Robert W. Baird maintained a "Buy" rating on Snowflake and set a target price of $350. The continued buy rating and high target price supported the stock price increase. The cloud computing industry is performing strongly, with increased demand for AI data clouds. **Top Gainers in Pre-market US Stocks** VolitionRx is up 96.55% in pre-market trading. Based on recent key news: 1. On August 26, VolitionRx transferred its Nu.Q NETs testing to the Sysmex platform and began discussions for broader commercial agreements. This move allows for the deployment of sepsis-focused testing on Sysmex analyzers, enhancing licensing prospects with major diagnostic groups. 2. On August 26, VolitionRx announced a 112% revenue growth in the first half of the year and achieved a significant milestone of $5 million in the veterinary field. This achievement is attributed to recent collaboration announcements and ongoing licensing discussions with twelve globally recognized diagnostic companies. 3. On August 25, VolitionRx identified other risks in its latest annual and quarterly reports and submitted them to the Securities and Exchange Commission. Industry collaboration and significant revenue growth have led to a positive market response. Mercer International is up 51.09% in pre-market trading. Based on recent key news: 1. On August 26, Mercer International announced that the Canadian government will provide CAD 20 million (approximately USD 14 million) in financial assistance for the operations of its subsidiary Mercer Peace River Pulp Ltd. This support aims to enhance MPR's production capacity and modernization, promoting bioenergy expansion and carbon capture projects. Following this announcement, the stock price surged. 2. On August 26, Mercer International disclosed details of the aforementioned financial assistance in SEC filings, including CAD 1 million as non-repayable funds and CAD 19 million as repayable funds, with a repayment period starting in 2031. This move further boosted investor confidence, driving the stock price up. 3. On August 26, the technical sentiment signal for Mercer International Inc. indicated a sell, but due to the announcement of government assistance, the market reacted positively, and the stock price rose against the trend. Recent industry policy support and significant capital inflow warrant attention to risks Uxin Technology pre-market rose 44.05%. Based on recent key news: 4. On August 27, Uxin Technology released its financial report, showing significant revenue growth. The company reported revenue of $1,883,254 for the six months ended March 31, a substantial increase from $346,013 in the same period last year, driving the stock price up. 5. On August 27, Uxin Technology announced through PR Newswire, emphasizing its disclosure of non-cash flow information. This announcement increased market confidence in the company's financial transparency, further supporting the rise in stock price. 6. On August 27, Uxin Technology's operating expenses increased significantly; however, the market reacted more positively to its revenue growth, leading to a rise in stock price. The technology sector has performed strongly recently, with noticeable capital inflows ### Related Stocks - [SNOW.US](https://longbridge.com/en/quote/SNOW.US.md) - [VNRX.US](https://longbridge.com/en/quote/VNRX.US.md) - [MERC.US](https://longbridge.com/en/quote/MERC.US.md) - [YAAS.US](https://longbridge.com/en/quote/YAAS.US.md) ## Related News & Research - [Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?](https://longbridge.com/en/news/297428659.md) - [Snowflake Earnings: What To Look For From SNOW](https://longbridge.com/en/news/297589687.md) - [16:11 ETOneSix Advances to Snowflake Elite Partner Status](https://longbridge.com/en/news/297557093.md) - [Snowflake CEO: Trusted Data, Not Model Benchmarks, Will Define Enterprise AI](https://longbridge.com/en/news/296945416.md) - [Oil prices rise as latest fighting resurrects Middle East supply disruption risks](https://longbridge.com/en/news/297575875.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**